Skip to content

Net Income at other companies

Bristol-Myers Squibb logo
Bristol-Myers SquibbBMY
$2.68B+9.0%
Johnson & Johnson logo
Johnson & JohnsonJNJ
$5.24B-52.4%
Neurocrine Biosciences logo
Neurocrine BiosciencesNBIX
$197.9M+2,405%
Acadia Pharmaceuticals logo
Acadia PharmaceuticalsACAD
$3.64M-80.8%
AbbVie logo
AbbVieABBV
$695M-46.0%
LBR
LB Pharmaceuticals Inc Common StockLBRX
-$19.05M-259%

Other financials

Income statement

See full
Operating income-$64.5M-174%
EPS (diluted)-$1.34+95.4%

Balance sheet

See full
Cash & equivalents$55.7M
Total debt$5.6M
Total equity$399.8M+285%
Total assets$418.8M

Cash flow

See full
Operating cash flow-$51.2M-100%
CapEx$24.0K
Free cash flow-$51.2M

Valuation

See full
Market cap$1.39B
Enterprise value$1.34B

Returns & leverage

See full
Return on equity-216.8%
Debt / equity
Current ratio22.9×

Where this comes from

Reported directly by MapLight Therapeutics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:NetIncomeLoss.

The official record: MapLight Therapeutics, Inc. ’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about MapLight Therapeutics, Inc. 's net income.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is MapLight Therapeutics, Inc. 's net income?
MapLight Therapeutics, Inc. (MPLT) reported net income of -$60.67M in Q1 2026.
How has MapLight Therapeutics, Inc. 's net income changed year-over-year?
MapLight Therapeutics, Inc. 's net income decreased by 171.6% year-over-year, from -$22.34M to -$60.67M.
What does net income mean?
The bottom line — total revenue minus all expenses, taxes, and costs. Represents the profit attributable to the company's shareholders after all obligations are met.